Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2020

Ausgabe 2/2020

Inhaltsverzeichnis ( 26 Artikel )

01.02.2020 | Review | Ausgabe 2/2020

Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials

Meng Li, Yiting Xiong, Chen Liao, Yunyan He, Sijia Duan, Fengming Yi, Yiping Wei, Wenxiong Zhang

06.02.2020 | Review | Ausgabe 2/2020

Management of brain metastases in breast cancer: a review of current practices and emerging treatments

Matthew N. Mills, Nicholas B. Figura, John A. Arrington, Hsiang-Hsuan Michael Yu, Arnold B. Etame, Michael A. Vogelbaum, Hatem Soliman, Brian J. Czerniecki, Peter A. Forsyth, Hyo S. Han, Kamran A. Ahmed

06.02.2020 | Review | Ausgabe 2/2020

Oncologic safety of immediate autologous fat grafting for reconstruction in breast-conserving surgery

Camile Cesa Stumpf, Ângela Erguy Zucatto, José Antônio Crespo Cavalheiro, Marcia Portela de Melo, Rodrigo Cericato, Andréa Pires Souto Damin, Jorge Villanova Biazús

29.01.2020 | Preclinical study | Ausgabe 2/2020

Increased number of intratumoral IL-17+ cells, a harbinger of the adverse prognosis of triple-negative breast cancer

Xiao-Long Qian, Peng Xu, Yi-Qian Zhang, Yuan-Ming Song, Ya-Qing Li, Wei-Dong Li, Cheng-Ying Jiang, Bei-Bei Shen, Xin-Min Zhang, Li-Na Zhang, Li Fu, Xiao-Jing Guo

30.01.2020 | Preclinical Study | Ausgabe 2/2020

Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma

Aidan C. Li, Jing Zhao, Chao Zhao, Zhongliang Ma, Ramon Hartage, Yunxiang Zhang, Xiaoxian Li, Anil V. Parwani

04.02.2020 | Preclinical study | Ausgabe 2/2020

Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer

Tomoko Shibayama, Siew-Kee Low, Makiko Ono, Takayuki Kobayashi, Kokoro Kobayashi, Ippei Fukada, Yoshinori Ito, Takayuki Ueno, Shinji Ohno, Yusuke Nakamura, Shunji Takahashi

04.02.2020 | Preclinical study | Ausgabe 2/2020

The role of Micro-CT in imaging breast cancer specimens

Daniel DiCorpo, Ankur Tiwari, Rong Tang, Molly Griffin, Owen Aftreth, Pinky Bautista, Kevin Hughes, Neil Gershenfeld, James Michaelson

06.02.2020 | Preclinical study | Ausgabe 2/2020

GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models

Shanchun Guo, Changde Zhang, Madhusoodanan Mottamal, Ahamed Hossain, Jiawang Liu, Guangdi Wang

07.02.2020 | Preclinical study | Ausgabe 2/2020

Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers

Dominique Yuan Bin Seow, Joe Poh Sheng Yeong, Johnathan Xiande Lim, Noel Chia, Jeffrey Chun Tatt Lim, Clara Chong Hui Ong, Puay Hoon Tan, Jabed Iqbal

07.02.2020 | Preclinical study | Ausgabe 2/2020 Open Access

pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1

MingMing Yu, YueHua Chen, ZhenGuang Wang, XiaoDong Ding

10.02.2020 | Preclinical Study | Ausgabe 2/2020

Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity

Charlotte Rypens, Melike Marsan, Christophe Van Berckelaer, Charlotte Billiet, Kirsten Melis, Sara Perez Lopez, Peter van Dam, Gayathri R. Devi, Pascal Finetti, Naoto T. Ueno, François Bertucci, Piet Dirix, Patrick Neven, Peter Vermeulen, Luc Dirix, Steven J. Van Laere

13.02.2020 | Preclinical study | Ausgabe 2/2020

Three-dimensional microanatomy of human nipple visualized by X-ray dark-field computed tomography

Naoki Sunaguchi, Daisuke Shimao, Tetsuya Yuasa, Shu Ichihara, Rieko Nishimura, Risa Oshima, Aya Watanabe, Kikuko Niwa, Masami Ando

04.02.2020 | Clinical trial | Ausgabe 2/2020 Open Access

Multiparametric radiomics methods for breast cancer tissue characterization using radiological imaging

Vishwa S. Parekh, Michael A. Jacobs

07.02.2020 | Clinical Trial | Ausgabe 2/2020

Neoadjuvant therapy and sentinel lymph node biopsy in HER2-positive breast cancer patients: results from the PEONY trial

Xiao Sun, Xue-Er Wang, Zhao-Peng Zhang, Zhi-Qiang Shi, Bin-Bin Cong, Yong-Sheng Wang, Zhi-Min Shao

10.02.2020 | Clinical trial | Ausgabe 2/2020

Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations

Matthew S. Katz, Linda McCall, Karla Ballman, Reshma Jagsi, Bruce G. Haffty, Armando E. Giuliano

30.01.2020 | Epidemiology | Ausgabe 2/2020 Open Access

Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White women

Erin Linnenbringer, Arline T. Geronimus, Kia L. Davis, John Bound, Libby Ellis, Scarlett L. Gomez

04.02.2020 | Epidemiology | Ausgabe 2/2020

Accelerated aging in breast cancer survivors and its association with mortality and cancer recurrence

Jingjing Zhu, Fei Wang, Liang Shi, Hui Cai, Ying Zheng, Wei Zheng, Pingping Bao, Xiao-Ou Shu

04.02.2020 | Epidemiology | Ausgabe 2/2020

The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society

Hyung Suk Kim, Tae Kyung Yoo, Woo Chan Park, Byung Joo Chae

10.02.2020 | Epidemiology | Ausgabe 2/2020

Male breast cancer: a closer look at patient and tumor characteristics and factors that affect survival using the National Cancer Database

Samuel Sarmiento, Michael McColl, Leila Musavi, Faiz Gani, Joseph K. Canner, Lisa Jacobs, Fanmeng Fu, Charalampos Siotos, Mehran Habibi

13.02.2020 | Epidemiology | Ausgabe 2/2020

Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990–2017

Zhilin Chen, Lu Xu, Wenjie Shi, Fanyu Zeng, Rui Zhuo, Xinbao Hao, Pingming Fan

14.02.2020 | Epidemiology | Ausgabe 2/2020

Trend and survival benefit of Oncotype DX use among female hormone receptor-positive breast cancer patients in 17 SEER registries, 2004–2015

Lu Zhang, Mei-Chin Hsieh, Valentina Petkov, Qingzhao Yu, Yu-wen Chiu, Xiao-Cheng Wu

28.01.2020 | Brief Report | Ausgabe 2/2020 Open Access

High risk of breast cancer in women with biallelic pathogenic variants in CHEK2

Irene Rainville, Shanell Hatcher, Eric Rosenthal, Katie Larson, Ryan Bernhisel, Stephanie Meek, Heidi Gorringe, Erin Mundt, Susan Manley

10.02.2020 | Brief Report | Ausgabe 2/2020

The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1)

Steven Sorscher, Katherine Ansley, Steven Douglas Delaney, Shakti Ramkissoon

10.02.2020 | Brief Report | Ausgabe 2/2020

High serum levels of periostin are associated with a poor survival in breast cancer

Tilman D. Rachner, Andy Göbel, Oliver Hoffmann, Kati Erdmann, Sabine Kasimir-Bauer, Dorit Breining, Rainer Kimmig, Lorenz C. Hofbauer, Ann-Kathrin Bittner

06.02.2020 | Letter to the Editor | Ausgabe 2/2020

CYP24A1 polymorphisms and breast cancer risk

Beuy Joob, Viroj Wiwanitkit

06.02.2020 | Abstracts | Ausgabe 2/2020

UK Interdisciplinary Breast Cancer Symposium 2020

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise